Your medical cannabis journey simplified: find partnered dispensaries, explore pricing options, earn rewards, and get answers to FAQs, all in one spot.
The news, which was officially announced in a letter, confirmed that the bank would no longer be granting new acquisitions or “short” positions in cannabis-focused businesses. However, the letter also noted that clients who already maintain such positions will be able to liquidate them.
“J.P. Morgan (JPMS) has introduced a framework that is designed to comply with U.S. money laundering laws and regulations by restricting certain activities in the securities of U.S. Marijuana Related Businesses,” reads an excerpt from the bank’s letter, which was addressed for the attention of its clients.
The bank’s decision comes hot off the heels of Credit Suisse’s $5.5 billion loss from the crash of the Archegos Capital Management investment fund. Numerous banks were left dealing with losses as a direct effect of this unexpected disaster. Since this time, wealth management firms have been forced to figure out exactly how much they’re willing to risk.
Cannabis’ Illegal Status Makes It Tricky for Banks to Offer Services
Although a swelling number of U.S. states have legalized cannabis for medical and/or recreational purposes, federal law still deems the plant to be an illicit substance. Consequently, banks that choose to collaborate with cannabis-focused businesses face the risk of being penalized for their actions.
Only specific cannabis-related businesses can list on the NASDAQ and NYSE, such as Canadian companies that do not carry out retail activities in the states. Conversely, companies that deal directly with cannabis cultivation or cannabis sales cannot list on the aforementioned stock exchanges.
Any U.S.-operating company that has a “direct nexus to cannabis-related activities” and does not list shares on the following stock exchanges must also abide by the restrictions:
NASDAQ
New York Stock Exchange
Toronto Stock Exchange
Nonetheless, many companies are skirting around the rules to continue trading on over-the-counter exchanges.
JPMorgan Chase’s New Framework Will Likely Disrupt Cannabis Stocks
A recent report published by MarketWatch confirmed that most cannabis company investors have been “burned by stock market losses” in 2021. Despite a poor performance this year, the sector is continuously growing as more U.S. states introduce legal adult-use markets. As of December 2021, a total of 18 U.S. states, Guam, and the District of Columbia have legalized cannabis for recreational use and sale.
Mainly, cannabis multi-state operators (MSOs) like Curaleaf Holdings (OTC:CURLF) and Trulieve Cannabis (OTC:TCNNF) will feel the effects of the financial institution’s decision. Why? Because cannabis’ federally illegal status in the U.S. means that such companies have no choice but to engage in OTC trading activities.
In addition to this, it’s likely that panic-selling from concerned investors could cause the cannabis stock market to struggle further now that JPMorgan Chase will stop offering new acquisitions or “short” positions in cannabis-focused businesses. Plus, the U.S. Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) issued a warning about delta-8 THC products back in September—something that is likely to put a strain on the cannabis sector moving forwards.
About JPMorgan Chase & Co.
JPMorgan Chase & Co. identifies as an American multinational investment bank. The financial services holding company is headquartered in New York City and was incorporated in Delaware. J.P. Morgan’s roots extend as far back as 1799, though the conversion of J.P. Morgan and Chase into JPMorgan Chase happened in 2000. Currently, the bank serves a broad scope of individuals and corporations in over 100 different countries.
Some of the world-renowned financial institution’s heritage firms include:
J.P. Morgan & Co.
Bank One
Chemical Bank
Manufacturers Hanover Trust Co.
National Bank of Detroit
Robert Fleming Holdings.
The Chase Manhattan Bank
The First National Bank of Chicago
The Bear Stearns Companies Inc.
Globally recognized for having top-rated finance technology and mobile banking services, JPMS prides itself on restructuring businesses to enhance their profitability and market permanence, not to mention the level of control maintained over the companies it collaborates with.
Aside from JPMS, another American bank that has been actively operating in the realm of cannabis trading is Cowen and Co. Back in September, the financial institution sent a letter to its clients outlining how it had decided to boost cash margin provisions for cannabis-associated trades on its platform.
Bethan Rose is a cannabis advocate, writer and traveler with no permanent address. Currently based in Bali, she can usually be found curating cannabis content on her hammock.
JP Morgans move is a good thing in the long run imo, as it shows the industry is maturing. Banks are going from gambling on cannabis to owning equity in it.
By traditional metrics, the decrease in call volume will be seen as bullish. I’m personally ready for some cannabis dividends though.
It’s undeniable that today’s cannabis isn’t the same as it was mere decades ago. While flower had an average tetrahydrocannabinol (THC) content of 4% in the 1990s, it’s not uncommon to now find cannabis strains with 25% THC or more. These strains are considered to be “high-THC.” High-THC cannabis is a hot topic that has…
The concept of “Wake and Bake” is pretty straightforward: wake up and get baked. While not all cannabis users like consuming cannabis in the morning, some find it to be a productive method for relieving pain, increasing focus, and jump-starting creativity. However, using cannabis in the morning can present unique challenges, including fatigue later on…
In the US, the laws determining the status of cannabis use vary from state to state and continue to change over time. Texas has one such cannabis program in flux, with a new bill being introduced that may change the legality of recreational marijuana within the state. What is the current legal status of cannabis…
Many canna-curious consumers exercise caution when choosing how much THC to ingest. If you are someone you know has ever experienced a high that is just too intense, many feel limited in how to remove themselves from the state they find themselves in. New products have emerged on the market to promote THC recovery for…
Not every option for cannabis storage is aesthetically pleasing or discreet. But even the most subtle stoners deserve a cute and secretive storage option, whether for storing your stash at home or taking it on the go. Discreet (And Cute!) Containers For Weed We compiled a wide-ranging list of cannabis storage options that are unique,…
The statements made regarding cannabis products on this website have not been evaluated by the Food and Drug Administration (FDA). Cannabis is not an FDA-approved substance and is still illegal under federal law. The information provided on this website is intended for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. It is not intended as medical advice and should not be considered as a substitute for advice from a healthcare professional. We strongly recommend that you consult with a physician or other qualified healthcare provider before using any cannabis products. The use of any information provided on this website is solely at your own risk.